骨髄性白血病 (JP Patent Analysis Report)
The Technical Field "骨髄性白血病" had 331 patent application filings in the most recent period (2023-01-01 to 2023-04-30). This is a significantly decreased of -634 filings (-65.7%) over 965 they had in the same period of the previous year (2022-01-01 to 2022-04-30). This report also includes technical terms related to " か粒球性白血病 ", " か粒球白血病 ", " 白血性白血病 ", " 白血性骨髄症 ", " 白血病性骨髄症 ", " 顆粒球性白血病 ", " 顆粒球白血病 ", " 骨髄芽球性白血病 ", " 骨髄芽細胞性白血病 ", " ML " in the search set.
The highest number of filings in 2019 with 3,670 cases, and their lowest number in 2023 with 624 cases.
The mean of the number of filings over the last 5 years (2019 to 2024, 13,462 cases in total) is 2,244, and the median is 2,919. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 2,244 patents |
| Std Dev | 1,358 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 624 cases | -77.4 % |
| 2022 year | 2,760 cases | -10.33 % |
| 2021 year | 3,078 cases | -4.08 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 骨髄性白血病 for the period of the last 10 years (2015-01-01 to 2024-12-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 骨髄性白血病, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
- Table of Contents
- Foreign Patent Analysis Report
- Patent Filing Summary for 骨髄性白血病
- Search Set (Search Formula/Analysis Patents)
- Related Patent Analysis Report
- Competitors Information
- Top company Information
- • Information on Important Patents
- Provision of patent information to the media
- About this Site
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
骨髄性白血病, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 骨髄性白血病 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 27,240 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
骨髄性白血病
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 骨髄性白血病 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, キヤノン株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 37 cases, followed by 三井化学株式会社 with 18 cases.
| Name | Cases |
|---|---|
| キヤノン株式会社 | 37 cases |
| 三井化学株式会社 | 18 cases |
| 花王株式会社 | 15 cases |
| 王子ホールディングス株式会社 | 13 cases |
| 東レ株式会社 | 10 cases |
| 住友化学株式会社 | 8 cases |
| コニカミノルタ株式会社 | 1 cases |
| 富士フイルム株式会社 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Comparing the number of applications of each company, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 289 cases, followed by 花王株式会社 with 183 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 289 cases |
| 花王株式会社 | 183 cases |
| キヤノン株式会社 | 178 cases |
| 富士フイルム株式会社 | 172 cases |
| 東レ株式会社 | 152 cases |
| 王子ホールディングス株式会社 | 146 cases |
| 三井化学株式会社 | 123 cases |
| 住友化学株式会社 | 112 cases |
| コニカミノルタ株式会社 | 29 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 骨髄性白血病 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Among the top coapplicants, キヤノン株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 37 cases, followed by 花王株式会社 with 15 cases.
| Name | Cases |
|---|---|
| キヤノン株式会社 | 37 cases |
| 花王株式会社 | 15 cases |
| 東レ株式会社 | 10 cases |
| コニカミノルタ株式会社 | 1 cases |
| 富士フイルム株式会社 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Among the top coapplicants, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 289 cases, followed by 花王株式会社 with 183 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 289 cases |
| 花王株式会社 | 183 cases |
| キヤノン株式会社 | 178 cases |
| 富士フイルム株式会社 | 172 cases |
| 東レ株式会社 | 152 cases |
| コニカミノルタ株式会社 | 29 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 骨髄性白血病’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 骨髄性白血病’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with コニカミノルタ株式会社
骨髄性白血病 filed 29 joint applications with コニカミノルタ株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 13 cases in total) is 2.2, and the median is 0.5. The coefficient of variation (standard deviation/mean) is 1.4, and there have been very big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2020 with 8 cases, and their lowest number in 2022 with 0 cases.
| Index | Value |
|---|---|
| Average | 2.2 patents |
| Std Dev | 3.0 |
| COV | 1.4 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | - |
| 2022 year | 0 cases | -100 % |
| 2021 year | 4 cases | -50.0 % |
Trends in filing of joint patent applications with 花王株式会社
骨髄性白血病 filed 183 joint applications with 花王株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 80 cases in total) is 13.3, and the median is 13.5. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2017 with 33 cases, and their lowest number in 2023 with 12 cases.
| Index | Value |
|---|---|
| Average | 13.3 patents |
| Std Dev | 5.5 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 12 cases | 0 |
| 2022 year | 12 cases | -40.0 % |
| 2021 year | 20 cases | +33.3 % |
Trends in filing of joint patent applications with キヤノン株式会社
骨髄性白血病 filed 178 joint applications with キヤノン株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 119 cases in total) is 19.8, and the median is 18.5. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2022 with 32 cases, and their lowest number in 2015 with 10 cases.
| Index | Value |
|---|---|
| Average | 19.8 patents |
| Std Dev | 9.2 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 30 cases | -6.25 % |
| 2022 year | 32 cases | +146 % |
| 2021 year | 13 cases | -7.14 % |
Trends in filing of joint patent applications with 東レ株式会社
骨髄性白血病 filed 152 joint applications with 東レ株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 76 cases in total) is 12.7, and the median is 13.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2019 with 24 cases, and their lowest number in 2023 with 9 cases.
| Index | Value |
|---|---|
| Average | 12.7 patents |
| Std Dev | 7.2 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 9 cases | -43.8 % |
| 2022 year | 16 cases | +60.0 % |
| 2021 year | 10 cases | -37.5 % |
Trends in filing of joint patent applications with 富士フイルム株式会社
骨髄性白血病 filed 172 joint applications with 富士フイルム株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 82 cases in total) is 13.7, and the median is 7.5. The coefficient of variation (standard deviation/mean) is 1.1, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2019 with 36 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 13.7 patents |
| Std Dev | 14.4 |
| COV | 1.1 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -50.0 % |
| 2022 year | 2 cases | -84.6 % |
| 2021 year | 13 cases | -56.7 % |
Information on important patents (JP)
The following shows JP patents held by 骨髄性白血病 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 骨髄性白血病’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 骨髄性白血病 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 8 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.2 times. The most recently Invalidation Trial patent is 特許5849947 "放出制御医薬組成物" (Invalidation Trial day 2024-09-17) , next is 特許7174020 "経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療" (Invalidation Trial day 2024-05-31) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許5849947 | 放出制御医薬組成物 | 2024-09-17 |
| 2 | 特許7174020 | 経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療 | 2024-05-31 |
| 3 | 特許6480887 | メトホルミン治療に不適切な患者における糖尿病の治療 | 2024-03-22 |
| 4 | 特許4974971 | 熱可塑性樹脂組成物とそれを用いた樹脂成形品および偏光子保護フィルムならびに樹脂成形品の製造方法 | 2023-07-27 |
| 5 | 特許6469123 | 中空糸膜型体液濾過装置、中空糸膜型体液濾過装置の作動方法及び濾過方法 | 2023-03-08 |
| 6 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 7 | 特許6397781 | 濃縮器 | 2022-07-01 |
| 8 | 特許6640164 | デクスメデトミジンを用いて小児患者を治療する方法 | 2022-04-28 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 14 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.1. The most invalidation trial patent is 特許6469123 "中空糸膜型体液濾過装置、中空糸膜型体液濾過装置の作動方法及び濾過方法" (2 times) , and the next most invalidation trial patent is 特許6480887 "メトホルミン治療に不適切な患者における糖尿病の治療" (2 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6469123 | 中空糸膜型体液濾過装置、中空糸膜型体液濾過装置の作動方法及び濾過方法 | 2 times |
| 2 | 特許6480887 | メトホルミン治療に不適切な患者における糖尿病の治療 | 2 times |
| 3 | 特許6274634 | 骨粗鬆症治療剤ないし予防剤 | 1 times |
| 4 | 特許6466538 | 治療薬のＣＮＳ送達 | 1 times |
| 5 | 特許6522072 | イズロン酸−２−スルファターゼのＣＮＳ送達のための方法および組成物 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 158 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7488634 "外用製剤" (Opposition day 2024-11-20) , next is 特許7486301 "排ガス処理触媒とその製造方法およびこれを用いた排ガス処理方法、並びに触媒の設計方法" (Opposition day 2024-11-18) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7488634 | 外用製剤 | 2024-11-20 |
| 2 | 特許7486301 | 排ガス処理触媒とその製造方法およびこれを用いた排ガス処理方法、並びに触媒の設計方法 | 2024-11-18 |
| 3 | 特許7486433 | 糖および甘味料の呈する味質が改善したコーヒー飲料 | 2024-11-15 |
| 4 | 特許7486432 | 糖および甘味料の呈する味質が改善したコーヒー飲料 | 2024-11-15 |
| 5 | 特許7482655 | 容器 | 2024-11-09 |
| 6 | 特許7478059 | シリコンのドライエッチング方法 | 2024-10-31 |
| 7 | 特許7481111 | プラスチックボトル | 2024-10-22 |
| 8 | 特許7472034 | ショベル、ショベル支援システム | 2024-10-18 |
| 9 | 特許7468852 | バリア素材 | 2024-10-16 |
| 10 | 特許7470242 | 焼鈍分離剤の製造方法及び焼鈍分離剤並びに方向性電磁鋼板 | 2024-10-15 |
Protested cases
List of latest Protested patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 394 patents Protest from third parties. The average number of Protest is 1.6 times. The most recently Protest patent is 特開2023-035088 "ビールテイスト飲料及びその製造方法" (Protest day 2024-12-26) , next is 特表2023-511850 "表面活性が変更されたヒュームドシリカ" (Protest day 2024-12-20) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2023-035088 | ビールテイスト飲料及びその製造方法 | 2024-12-26 |
| 2 | 特表2023-511850 | 表面活性が変更されたヒュームドシリカ | 2024-12-20 |
| 3 | 特開2024-064797 | 酸化マグネシウム顆粒及びそれを含有する酸化マグネシウム錠剤及び細粒剤、並びにそれらの製造方法 | 2024-12-13 |
| 4 | 特開2023-100665 | 栄養製品 | 2024-12-13 |
| 5 | 特開2024-080258 | メロン果汁入り飲料およびメロン果汁入り飲料の製造方法 | 2024-12-10 |
| 6 | 特許7610645 | キシリレンジイソシアネート組成物、キシリレンジイソシアネート変性体組成物、重合性組成物、樹脂、成形体、光学素子およびレンズ | 2024-12-09 |
| 7 | 特開2023-181897 | ビール風味発酵アルコール飲料およびその製法 | 2024-12-04 |
| 8 | 特開2023-072029 | 甘味の増大した飲食品 | 2024-12-04 |
| 9 | 特表2024-543131 | 高発酵度ビールの製造 | 2024-11-29 |
| 10 | 特開2024-155234 | 医療用ゴム組成物および医療用ゴム製品 | 2024-11-29 |
| 11 | 特開2024-042645 | ブレダーミックス | 2024-11-26 |
| 12 | 特開2024-155273 | 殺菌剤組成物 | 2024-11-26 |
| 13 | 特開2022-001631 | セルロース繊維の乾燥粉体の製造方法 | 2024-11-25 |
| 14 | 特開2023-110302 | 脂肪族アルコールを含有する飲料 | 2024-11-25 |
| 15 | 特開2023-111050 | 除菌方法、除菌組成物、除菌製品及び除菌組成物の効力向上方法 | 2024-11-21 |
| 16 | 特開2023-005587 | 雑味が低減された低エキスアルコール飲料およびその製造方法 | 2024-11-20 |
| 17 | 特開2023-108019 | 発酵アルコール飲料の製造方法並びにビールテイスト飲料及びワインテイスト飲料 | 2024-11-18 |
| 18 | 特開2022-180982 | 容器詰めアルコール飲料及びその製造方法 | 2024-11-15 |
| 19 | 特表2022-500417 | 咬筋肥大症の治療方法 | 2024-11-13 |
| 20 | 特開2024-096506 | 外用製剤 | 2024-11-12 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 799 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.5. The most protest patent is 特許7237443 "ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の香味を改善する方法" (10 times) , and the next most protest patent is 特許7297402 "ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の麦由来の雑味のキレを改善する方法" (9 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7237443 | ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の香味を改善する方法 | 10 times |
| 2 | 特許7297402 | ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の麦由来の雑味のキレを改善する方法 | 9 times |
| 3 | 特許7544562 | 害虫、ダニ防除方法、及び害虫、ダニ防除用エアゾール | 7 times |
| 4 | 特許6901968 | 有機重合体微粒子 | 6 times |
| 5 | 特許7455408 | 高温で保存される清酒の製造方法及び保存方法 | 6 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 754 patents Inspection from third parties. The average number of Inspection is 2.1 times. The most recently Inspection patent is 特表2024-543131 "高発酵度ビールの製造" (Inspection day 2024-12-27) , next is 特表2022-550734 "ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ＭＰＩ）を改善する方法" (Inspection day 2024-12-27) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2024-543131 | 高発酵度ビールの製造 | 2024-12-27 |
| 2 | 特表2022-550734 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ＭＰＩ）を改善する方法 | 2024-12-27 |
| 3 | 特許7378463 | 麦汁フレーバーが低減された低アルコールビール | 2024-12-25 |
| 4 | 特開2024-155234 | 医療用ゴム組成物および医療用ゴム製品 | 2024-12-24 |
| 5 | 特許7610645 | キシリレンジイソシアネート組成物、キシリレンジイソシアネート変性体組成物、重合性組成物、樹脂、成形体、光学素子およびレンズ | 2024-12-18 |
| 6 | 特開2024-080258 | メロン果汁入り飲料およびメロン果汁入り飲料の製造方法 | 2024-12-18 |
| 7 | 特開2024-064797 | 酸化マグネシウム顆粒及びそれを含有する酸化マグネシウム錠剤及び細粒剤、並びにそれらの製造方法 | 2024-12-17 |
| 8 | 特表2022-517939 | 医薬組成物 | 2024-12-17 |
| 9 | 特開2023-024691 | 形質導入および細胞プロセシングのための方法 | 2024-12-17 |
| 10 | 特表2022-539388 | ＣＣＬ１４の抗体およびアッセイ | 2024-12-13 |
| 11 | 特表2022-513062 | Ｂ細胞悪性腫瘍を処置するために、操作されたＴ細胞を投薬する方法 | 2024-12-10 |
| 12 | 特表2023-509263 | アフリベルセプトをコードするＡＡＶ２バリアントを使用する眼内血管新生疾患を処置する方法 | 2024-12-10 |
| 13 | 特表2022-516496 | キメラ受容体ポリペプチド及びその使用 | 2024-12-10 |
| 14 | 特開2024-155273 | 殺菌剤組成物 | 2024-12-10 |
| 15 | 特開2023-181897 | ビール風味発酵アルコール飲料およびその製法 | 2024-12-09 |
| 16 | 特表2021-519758 | ＬＦＡ３バリアントならびにその組成物および使用法 | 2024-12-06 |
| 17 | 特開2022-180982 | 容器詰めアルコール飲料及びその製造方法 | 2024-12-05 |
| 18 | 特表2021-525549 | 腫瘍特異的ネオ抗原およびその使用方法 | 2024-12-04 |
| 19 | 特開2023-012459 | 共沈によるサブミクロン範囲内の非晶質固体分散物の製造方法 | 2024-12-02 |
| 20 | 特表2021-532776 | 造血細胞の遺伝子改変のための方法 | 2024-11-29 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 1,371 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.7. The most inspection patent is 特許7297402 "ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の麦由来の雑味のキレを改善する方法" (26 times) , and the next most inspection patent is 特許7237443 "ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の香味を改善する方法" (19 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7297402 | ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の麦由来の雑味のキレを改善する方法 | 26 times |
| 2 | 特許7237443 | ビールテイスト飲料、ビールテイスト飲料の製造方法、及びビールテイスト飲料の香味を改善する方法 | 19 times |
| 3 | 特許6931179 | 無水酢酸ナトリウム結晶の製造方法及び無水酢酸ナトリウム結晶 | 16 times |
| 4 | 特許6758099 | 果実フレーバーを含有する透明飲料 | 15 times |
| 5 | 特許7164559 | ビールテイスト飲料 | 14 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 4,928 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.5. The most cited patent is 特許6805244 "有機スズオキシドヒドロキシドのパターン形成組成物、前駆体およびパターン形成" (54 times) , and the next most cited patent is 特許7246191 "乳固形分と果実フレーバーを含むコーヒー飲料" (52 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6805244 | 有機スズオキシドヒドロキシドのパターン形成組成物、前駆体およびパターン形成 | 54 times |
| 2 | 特許7246191 | 乳固形分と果実フレーバーを含むコーヒー飲料 | 52 times |
| 3 | 特許7185009 | 細胞トランスフェクションのエレクトロポレーション装置及び方法 | 39 times |
| 4 | 特許6901233 | ビールテイスト飲料の呈味改善方法 | 39 times |
| 5 | 特許6976503 | 遊技台 | 36 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.